cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA377382 | synovial membrane | .a | 3883 to 4178 | 1 to 296 | 296/296 (100 %) | 0 diff (100 %id) | |||
AF411226 | .a | 110 to 3720 | 1 to 3611 | exact | tiling clone, | 3611/3611 (100 %) | 0 diff (100 %id) | ||
AF501310 | .a | 70 to 3720 | 1 to 3651 | exact | 3651/3651 (100 %) | 1 diff (100.0 %id) | |||
DA018398 | .a | 5191 to 5749 | 2 to 560 | tiling clone, capped | 559/559 (100 %) | 1 diff (99.9 %id) | |||
AI907831 | breast | .a | 7482 to 7659 | 181 to 5 | 177/187 (94 %) | 0 diff (100 %id) | |||
AJ705764 | bone marrow | .f | 171 to 634 | 10 to 473 | exact | tiling clone, | 464/473 (98 %) | 6 diff (98.8 %id) | |
AJ709693 | heart | .a | 2449 to 2927 | 483 to 2 | Submitted on the opposite strand | 482/483 (99 %) | 0 diff (100 %id) | ||
AK000745 | .a | 615 to 3720 | 1 to 3106 | available from FLJ, | 3106/3106 (100 %) | 0 diff (100 %id) | |||
AK123083 | .a | 5506 to 7666 | 1 to 2161 | tiling clone, available from FLJ, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 2161/2161 (100 %) | 4 diff (99.9 %id) | ||
AK308030 | .c | 237 to 1466 | 1 to 1231 | tiling clone, | 1231/1231 (100 %) | 2 diff (99.9 %id) | |||
DA020947 | .a | 5507 to 6067 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | |||
DA031537 | .a | 613 to 1203 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | |||
AW059783 | .a | 3455 to 3624 | 170 to 1 | 170/170 (100 %) | 1 diff (99.5 %id) | ||||
AW362107 | colon | .a | 3386 to 3617 | 233 to 2 | 232/233 (99 %) | 0 diff (100 %id) | |||
AW362118 | colon | .a | 3284 to 3639 | 359 to 5 | 355/372 (95 %) | 0 diff (100 %id) | |||
AW362119 | colon | .a | 3327 to 3640 | 326 to 15 | 312/326 (95 %) | 0 diff (100 %id) | |||
AW371035 | breast | .b | 1027 to 1504 | 53 to 529 | 477/529 (90 %) | 9 diff (98.3 %id) | |||
AW380401 | head_neck | .a | 3284 to 3471 | 189 to 2 | 188/196 (95 %) | 0 diff (100 %id) | |||
AW394137 | testis | .b | 983 to 1520 | 10 to 546 | 537/546 (98 %) | 12 diff (97.9 %id) | |||
AW394138 | testis | .b | 989 to 1548 | 15 to 572 | 558/573 (97 %) | 21 diff (96.4 %id) | |||
AW394139 | testis | .b | 989 to 1569 | 36 to 613 | 578/627 (92 %) | 22 diff (96.5 %id) | |||
AW394158 | testis | .b | 983 to 1503 | 10 to 530 | 521/530 (98 %) | 12 diff (97.8 %id) | |||
AW748792 | breast | .a | 1271 to 1930 | 658 to 1 | 658/660 (99 %) | 6 diff (99.1 %id) | |||
AW804033 | uterus | .a | 1912 to 2124 | 232 to 21 | 212/236 (89 %) | 4 diff (98.4 %id) | |||
AW834403 | testis | .b | 1169 to 1461 | 1 to 293 | 293/293 (100 %) | 16 diff (94.6 %id) | |||
AW834404 | testis | .a | 1671 to 1849 | 184 to 6 | 179/184 (97 %) | 1 diff (99.5 %id) | |||
AW855255 | colon | .a | 3285 to 3586 | 307 to 1 | 307/330 (93 %) | 24 diff (92.8 %id) | |||
AW867780 | stomach_normal | .a | 1549 to 1824 | 311 to 36 | 276/311 (88 %) | 0 diff (100 %id) | |||
AW867782 | stomach_normal | .a | 1549 to 1854 | 321 to 20 | 303/321 (94 %) | 1 diff (99.7 %id) | |||
AW895650 | nervous_normal | .a | 1549 to 1849 | 300 to 3 | 298/300 (99 %) | 0 diff (100 %id) | |||
AW895777 | nervous_normal | .a | 1549 to 1854 | 326 to 19 | 308/326 (94 %) | 2 diff (99.4 %id) | |||
AW895981 | nervous_normal | .a | 1549 to 1854 | 333 to 29 | 305/333 (91 %) | 1 diff (99.7 %id) | |||
AW968528 | .a | 2707 to 3363 | 657 to 1 | Submitted on the opposite strand | 657/661 (99 %) | 5 diff (99.3 %id) | |||
AW973012 | .a | 7316 to 7664 | 399 to 51 | Submitted on the opposite strand | 349/488 (71 %) | 0 diff (100 %id) | |||
AY082966 | colon carcinoma | .a | 251 to 2281 | 1 to 2031 | exact | 2031/2031 (100 %) | 0 diff (100 %id) | ||
AY974040 | .a | 259 to 2078 | 1 to 1820 | Q145H T543A E581D | 1820/1820 (100 %) | 5 diff (99.8 %id) | |||
Z25307 | leg muscle, skeletal muscle | .a | 5001 to 5317 | 1 to 317 | tiling clone, | 317/319 (99 %) | 1 diff (99.7 %id) | ||
BC045642 | testis | .a | 1 to 3714 | 1 to 3714 | A78S T317A | tiling clone, available from MGC, AAA | 3714/3714 (100 %) | 2 diff (100.0 %id) | |
BE004270 | breast_normal | .a | 3021 to 3198 | 179 to 2 | Submitted on the opposite strand | 178/179 (99 %) | 0 diff (100 %id) | ||
BE004887 | breast_normal | .a | 1912 to 2116 | 209 to 5 | Submitted on the opposite strand | 205/211 (97 %) | 5 diff (97.7 %id) | ||
BE063401 | breast | .b | 1027 to 1504 | 53 to 529 | 477/529 (90 %) | 9 diff (98.3 %id) | |||
BE079256 | breast | .a | 3636 to 4248 | 625 to 13 | tiling clone, | Submitted on the opposite strand | 613/625 (98 %) | 0 diff (100 %id) | |
BE150819 | head_neck | .a | 1362 to 1848 | 487 to 1 | Submitted on the opposite strand | 487/487 (100 %) | 10 diff (98.0 %id) | ||
BE153111 | head_neck | .a | 3458 to 3923 | 470 to 2 | Submitted on the opposite strand | 469/474 (98 %) | 0 diff (100 %id) | ||
BE696145 | colon | .a | 3284 to 3639 | 368 to 14 | 355/382 (92 %) | 0 diff (100 %id) | |||
BE696156 | colon | .a | 3386 to 3639 | 266 to 14 | 253/266 (95 %) | 0 diff (100 %id) | |||
BE774144 | uterus | .a | 4070 to 4374 | 309 to 5 | 305/309 (98 %) | 0 diff (100 %id) | |||
BE814967 | breast_normal | .a | 1912 to 2126 | 220 to 7 | 214/222 (96 %) | 6 diff (97.3 %id) | |||
BE825593 | lung_normal | .a | 895 to 1286 | 410 to 14 | 397/458 (86 %) | 10 diff (97.9 %id) | |||
BF335327 | colon | .a | 2987 to 3093 | 120 to 15 | 106/120 (88 %) | 0 diff (100 %id) | |||
BF336348 | colon | .a | 3151 to 3484 | 338 to 9 | 330/340 (97 %) | 0 diff (100 %id) | |||
BF336351 | colon | .a | 3160 to 3457 | 298 to 1 | 298/298 (100 %) | 3 diff (99.0 %id) | |||
BF336352 | colon | .a | 3160 to 3457 | 295 to 1 | 295/295 (100 %) | 6 diff (98.0 %id) | |||
BF336359 | colon | .a | 3160 to 3258 | 103 to 5 | 99/103 (96 %) | 0 diff (100 %id) | |||
BF336360 | colon | .a | 3160 to 3490 | 330 to 1 | 330/330 (100 %) | 2 diff (99.4 %id) | |||
BF336361 | colon | .a | 3160 to 3484 | 330 to 5 | 326/330 (98 %) | 0 diff (100 %id) | |||
BF336362 | colon | .a | 3160 to 3490 | 330 to 1 | 330/330 (100 %) | 4 diff (98.8 %id) | |||
BF351350 | head_neck | .a | 1539 to 2063 | 535 to 6 | 530/536 (98 %) | 10 diff (98.2 %id) | |||
BF357515 | head_neck | .a | 3225 to 3379 | 163 to 8 | 156/163 (95 %) | 0 diff (100 %id) | |||
BF357539 | head_neck | .a | 3297 to 3483 | 193 to 9 | 185/193 (95 %) | 0 diff (100 %id) | |||
BF357540 | head_neck | .a | 3297 to 3482 | 188 to 3 | 186/188 (98 %) | 0 diff (100 %id) | |||
BF369225 | placenta_normal | .a | 3160 to 3490 | 331 to 1 | 331/331 (100 %) | 5 diff (98.5 %id) | |||
BF380996 | uterus_tumor | .a | 3225 to 3514 | 299 to 13 | 287/299 (95 %) | 0 diff (100 %id) | |||
BF381001 | uterus_tumor | .a | 3210 to 3500 | 326 to 35 | 292/326 (89 %) | 0 diff (100 %id) | |||
BF752734 | breast_normal | .a | 1965 to 2284 | 318 to 3 | Submitted on the opposite strand | 316/382 (82 %) | 1 diff (99.8 %id) | ||
BF839238 | head_neck | .a | 1658 to 2048 | 396 to 8 | Submitted on the opposite strand | 389/584 (66 %) | 6 diff (99.0 %id) | ||
BF839338 | head_neck | .a | 1658 to 2048 | 396 to 8 | Submitted on the opposite strand | 389/584 (66 %) | 6 diff (99.0 %id) | ||
BF898143 | marrow | .a | 1401 to 1750 | 349 to 1 | Submitted on the opposite strand | 349/349 (100 %) | 9 diff (97.5 %id) | ||
BF959654 | nervous_normal | .m-u | 39 to 464 | 442 to 17 | Q8R T11A M13V | tiling clone, | 426/443 (96 %) | 0 diff (100 %id) | |
BI032591 | nervous_normal | .m-u | 1 to 346 | 361 to 16 | Q8R T11A M13V P28A S38G | tiling clone, | 346/361 (95 %) | 0 diff (100 %id) | |
BM504853 | Pancreas, Purified pancreatic islet | .a | 3622 to 4186 | 11 to 575 | 565/575 (98 %) | 6 diff (99.0 %id) | |||
BQ317951 | colon | .a | 3426 to 3639 | 244 to 20 | 225/244 (92 %) | 0 diff (100 %id) | |||
BQ317952 | colon | .a | 3284 to 3442 | 169 to 13 | 157/176 (89 %) | 0 diff (100 %id) | |||
BQ320150 | colon | .a | 1012 to 1354 | 350 to 10 | 341/350 (97 %) | 0 diff (100 %id) | |||
BQ325103 | colon_ins | .a | 1182 to 1689 | 516 to 12 | 505/516 (97 %) | 5 diff (99.1 %id) | |||
BQ337952 | nervous_normal | .a | 1536 to 1839 | 301 to 1 | 301/301 (100 %) | 5 diff (98.4 %id) | |||
BQ351859 | head_neck | .a | 1613 to 1940 | 347 to 20 | 328/347 (94 %) | 7 diff (98.0 %id) | |||
BQ378423 | uterus_tumor | .a | 3158 to 3460 | 309 to 3 | 307/310 (99 %) | 0 diff (100 %id) | |||
BQ378425 | uterus_tumor | .a | 3151 to 3468 | 329 to 9 | 321/338 (94 %) | 0 diff (100 %id) | |||
BQ378457 | uterus_tumor | .a | 3161 to 3490 | 342 to 14 | 329/343 (95 %) | 0 diff (100 %id) | |||
DA061691 | cerebellum | .a | 5507 to 6080 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | ||
DA182314 | amygdala | .a | 5397 to 5972 | 2 to 577 | capped | 576/576 (100 %) | 0 diff (100 %id) | ||
DA213697 | brain | .a | 1149 to 1693 | 2 to 546 | capped | 545/545 (100 %) | 0 diff (100 %id) | ||
DA258719 | caudate nucleus | .a | 1451 to 2013 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
BF727404 | eye, lens | .e | 113 to 572 | 1 to 460 | 460/460 (100 %) | 0 diff (100 %id) | |||
C00164 | .a | 1592 to 1654 | 1 to 63 | 63/63 (100 %) | 0 diff (100 %id) | ||||
CD239967 | Pituitary | .a | 2354 to 3082 | 1 to 729 | 729/729 (100 %) | 0 diff (100 %id) | |||
CN302137 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 3000 to 3608 | 1 to 609 | 609/614 (99 %) | 1 diff (99.9 %id) | |||
CN302138 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 2850 to 3523 | 1 to 673 | 673/673 (100 %) | 2 diff (99.8 %id) | |||
CN302140 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 3311 to 3761 | 1 to 451 | 451/451 (100 %) | 0 diff (100 %id) | |||
CN302141 | embryonic stem cells, DMSO-treated H9 cellline | .a | 6574 to 7333 | 1 to 760 | 760/760 (100 %) | 0 diff (100 %id) | |||
CN425848 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .e | 75 to 398 | 1 to 324 | 324/324 (100 %) | 0 diff (100 %id) | |||
CN425852 | embryonic stem cells, DMSO-treated H9 cellline | .e | 298 to 609 | 1 to 312 | 312/312 (100 %) | 0 diff (100 %id) | |||
CR590400 | thymus | .a | 2665 to 3688 | 1 to 1024 | 1024/1024 (100 %) | 0 diff (100 %id) | |||
CR606229 | B cells (Ramos cell line) Cot 25-normalized | .a | 130 to 2004 | 1 to 1875 | 1875/1875 (100 %) | 0 diff (100 %id) | |||
CR742320 | brain, glioblastoma (pooled) | .a | 3208 to 3680 | 1 to 473 | 473/473 (100 %) | 0 diff (100 %id) | |||
BX414677 | thymus | .a | 2665 to 3709 | 1 to 1033 | 1033/1043 (99 %) | 19 diff (98.2 %id) | |||
DA450263 | tongue, tumor tissue | .a | 1973 to 2528 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
DC297345 | .b | 962 to 1543 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | ||||
DA480770 | .a | 830 to 1384 | 2 to 556 | capped | 555/555 (100 %) | 0 diff (100 %id) | |||
AL041727 | testis | .a | 3406 to 3690 | 285 to 1 | 285/285 (100 %) | 0 diff (100 %id) | |||
AL706409 | human skeletal muscle | .i | 1 to 602 | 1 to 602 | exact | tiling clone, | 602/602 (100 %) | 2 diff (99.7 %id) | |
BX498530 | Liver | .a | 7110 to 7553 | 1 to 444 | 444/444 (100 %) | 0 diff (100 %id) | |||
BX502398 | Liver | .j-u | 180 to 683 | 1 to 506 | 506/506 (100 %) | 5 diff (99.1 %id) | |||
DT217223 | brain | .a | 2585 to 3214 | 1 to 629 | 629/629 (100 %) | 1 diff (99.9 %id) | |||
DW416354 | Liver | .a | 3858 to 4151 | 16 to 309 | 294/309 (95 %) | 6 diff (98.1 %id) | |||
DW426198 | Liver | .c | 1 to 267 | 17 to 283 | tiling clone, | 267/283 (94 %) | 6 diff (97.9 %id) | ||
EC454442 | Prostate | .a | 1821 to 1914 | 1 to 94 | 94/94 (100 %) | 5 diff (94.7 %id) | |||
EC457133 | Prostate | .a | 1251 to 1350 | 1 to 100 | 100/100 (100 %) | 0 diff (100 %id) | |||
EC522143 | Prostate | .a | 1207 to 1291 | 1 to 84 | 84/84 (100 %) | 1 diff (98.9 %id) | |||
EC527738 | Prostate | .a | 1943 to 2043 | 101 to 1 | 101/102 (99 %) | 6 diff (94.2 %id) | |||
EC569579 | Prostate | .a | 2023 to 2141 | 117 to 1 | 117/117 (100 %) | 4 diff (96.6 %id) | |||
ES312260 | frontal balding hair, skin | .a | 3246 to 3406 | 1 to 162 | 162/162 (100 %) | 1 diff (99.4 %id) | |||
ES315596 | occipital scalp hair, skin | .a | 5552 to 5663 | 1 to 112 | 112/112 (100 %) | 0 diff (100 %id) | |||
ES316198 | pool of melanoma cell lines | .a | 1820 to 2162 | 405 to 64 | Submitted on the opposite strand | 342/475 (72 %) | 6 diff (98.8 %id) | ||
EY198520 | intestinal (Lauren) gastric adenocarcinoma, stomach | .a | 1831 to 2161 | 329 to 1 | Submitted on the opposite strand | 329/329 (100 %) | 1 diff (99.7 %id) | ||
DA504729 | brain | .a | 2939 to 3508 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DA510324 | brain | .a | 2085 to 2671 | 2 to 588 | capped | 587/587 (100 %) | 0 diff (100 %id) | ||
FN068078 | breast carcinoma | .a | 4090 to 4174 | 93 to 10 | Submitted on the opposite strand | 84/93 (90 %) | 0 diff (100 %id) | ||
FN071830 | breast carcinoma | .a | 865 to 938 | 1 to 74 | 74/75 (98 %) | 4 diff (94.7 %id) | |||
FN083480 | breast carcinoma | .a | 1390 to 1472 | 1 to 82 | 82/83 (98 %) | 2 diff (97.6 %id) | |||
FN093770 | breast carcinoma | .a | 2437 to 2536 | 1 to 97 | 97/97 (100 %) | 3 diff (97.0 %id) | |||
FN093984 | breast carcinoma | .a | 1139 to 1222 | 81 to 1 | Submitted on the opposite strand | 81/83 (97 %) | 3 diff (96.4 %id) | ||
FN096957 | breast carcinoma | .a | 1166 to 1260 | 1 to 91 | 91/91 (100 %) | 5 diff (94.6 %id) | |||
FN099727 | breast carcinoma | .a | 1268 to 1342 | 75 to 1 | Submitted on the opposite strand | 75/76 (98 %) | 0 diff (100 %id) | ||
FN105349 | breast carcinoma | .a | 3468 to 3576 | 1 to 108 | 108/110 (98 %) | 2 diff (98.2 %id) | |||
FN108844 | breast carcinoma | .a | 3459 to 3526 | 1 to 68 | 68/68 (100 %) | 0 diff (100 %id) | |||
FN114974 | breast carcinoma | .a | 3068 to 3171 | 1 to 111 | 111/111 (100 %) | 5 diff (95.5 %id) | |||
FN117793 | breast carcinoma | .a | 3429 to 3527 | 100 to 1 | Submitted on the opposite strand | 100/100 (100 %) | 1 diff (99.0 %id) | ||
FN119774 | breast carcinoma | .a | 2902 to 3011 | 109 to 1 | Submitted on the opposite strand | 109/109 (100 %) | 2 diff (98.2 %id) | ||
FN120674 | breast carcinoma | .a | 3326 to 3438 | 112 to 1 | Submitted on the opposite strand | 112/112 (100 %) | 6 diff (94.7 %id) | ||
FN124228 | breast carcinoma | .a | 2691 to 2800 | 110 to 5 | Submitted on the opposite strand | 106/110 (96 %) | 0 diff (100 %id) | ||
FN128608 | breast carcinoma | .a | 3347 to 3453 | 1 to 104 | 104/104 (100 %) | 4 diff (96.2 %id) | |||
FN129580 | breast carcinoma | .a | 7498 to 7552 | 1 to 55 | 55/62 (88 %) | 3 diff (95.2 %id) | |||
FN130828 | breast carcinoma | .a | 1490 to 1575 | 85 to 1 | Submitted on the opposite strand | 85/85 (100 %) | 1 diff (98.9 %id) | ||
FN131008 | breast carcinoma | .a | 1327 to 1422 | 1 to 92 | 92/96 (95 %) | 9 diff (90.7 %id) | |||
FN135406 | breast carcinoma | .a | 2854 to 2958 | 1 to 101 | 101/102 (99 %) | 6 diff (94.2 %id) | |||
FN142223 | breast carcinoma | .a | 3625 to 3718 | 1 to 93 | 93/97 (95 %) | 2 diff (98.0 %id) | |||
FN160328 | breast carcinoma | .a | 3012 to 3115 | 103 to 1 | Submitted on the opposite strand | 103/103 (100 %) | 2 diff (98.1 %id) | ||
FN163887 | breast carcinoma | .a | 1191 to 1287 | 99 to 1 | Submitted on the opposite strand | 99/110 (90 %) | 5 diff (95.5 %id) | ||
FN164868 | breast carcinoma | .a | 3036 to 3113 | 1 to 76 | 76/81 (93 %) | 4 diff (95.1 %id) | |||
FN166634 | breast carcinoma | .a | 3374 to 3466 | 96 to 1 | Submitted on the opposite strand | 96/98 (97 %) | 0 diff (100 %id) | ||
DB454712 | testis | .e | 30 to 510 | 1 to 481 | 481/481 (100 %) | 0 diff (100 %id) | |||
DB520123 | testis | .a | 3270 to 3720 | 1 to 449 | Submitted on the opposite strand | 449/449 (100 %) | 1 diff (99.8 %id) | ||
DB457464 | testis | .e | 52 to 520 | 1 to 469 | 469/469 (100 %) | 0 diff (100 %id) | |||
DB522939 | testis | .a | 3261 to 3720 | 1 to 460 | Submitted on the opposite strand | 460/460 (100 %) | 1 diff (99.8 %id) | ||
DB461713 | testis | .e | 2 to 481 | 1 to 480 | 480/480 (100 %) | 1 diff (99.8 %id) | |||
DB527133 | testis | .a | 3261 to 3720 | 1 to 460 | Submitted on the opposite strand | 460/460 (100 %) | 0 diff (100 %id) | ||
DB544908 | hippocampus | .a | 3277 to 3720 | 1 to 444 | Submitted on the opposite strand | 444/444 (100 %) | 0 diff (100 %id) | ||
DB505501 | hypothalamus | .e | 220 to 675 | 1 to 456 | 456/465 (98 %) | 3 diff (99.4 %id) | |||
DB576778 | hypothalamus | .a | 3234 to 3720 | 1 to 487 | Submitted on the opposite strand | 487/487 (100 %) | 0 diff (100 %id) | ||
AI754495 | bone marrow stroma | .a | 3238 to 3722 | 503 to 19 | AAA | 485/485 (100 %) | 0 diff (100 %id) | ||
DC355948 | .b | 971 to 1524 | 1 to 554 | 554/554 (100 %) | 2 diff (99.7 %id) | ||||
DA569734 | whole embryo, mainly head | .a | 2249 to 3117 | 2 to 875 | capped | 874/874 (100 %) | 11 diff (98.8 %id) | ||
DB356426 | whole embryo, mainly head | .a | 3171 to 3720 | 547 to 1 | 547/547 (100 %) | 5 diff (99.1 %id) | |||
DA571422 | whole embryo, mainly head | .a | 2327 to 3136 | 2 to 811 | capped | 810/810 (100 %) | 3 diff (99.7 %id) | ||
BP417461 | small intestine | .a | 3155 to 3531 | 1 to 377 | Submitted on the opposite strand | 377/377 (100 %) | 0 diff (100 %id) | ||
BJ989418 | hepatoblastoma | .a | 1307 to 1656 | 11 to 360 | 350/360 (97 %) | 7 diff (98.1 %id) | |||
BJ992213 | hepatoblastoma | .a | 1720 to 2307 | 1 to 588 | 588/588 (100 %) | 0 diff (100 %id) | |||
DA598887 | .h | 1 to 564 | 2 to 565 | tiling clone, capped | 564/564 (100 %) | 1 diff (99.9 %id) | |||
CN483680 | eye | .a | 2835 to 3361 | 1 to 527 | 527/527 (100 %) | 0 diff (100 %id) | |||
T48108 | fetal spleen, Spleen | .a | 1946 to 2043 | 98 to 1 | 98/98 (100 %) | 0 diff (100 %id) | |||
H88688 | cochlea, ear | .a | 3507 to 3721 | 1 to 215 | 215/215 (100 %) | 0 diff (100 %id) | |||
N67425 | cochlea, ear | .a | 7522 to 7659 | 138 to 1 | 138/138 (100 %) | 0 diff (100 %id) | |||
W37567 | parathyroid gland, parathyroid tumor | .a | 1244 to 1654 | 433 to 20 | AAA | Submitted on the opposite strand | 414/414 (100 %) | 3 diff (99.3 %id) | |
W37474 | parathyroid gland, parathyroid tumor | .e | 108 to 635 | 1 to 551 | Submitted on the opposite strand | 551/560 (98 %) | 33 diff (94.2 %id) | ||
W37660 | parathyroid gland, parathyroid tumor | .a | 1098 to 1655 | 561 to 1 | Submitted on the opposite strand | 561/563 (99 %) | 5 diff (99.2 %id) | ||
AA115942 | uterus | .a | 7275 to 7658 | 398 to 14 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 385/385 (100 %) | 0 diff (100 %id) | |
AA122239 | uterus | .a | 6787 to 7305 | 1 to 520 | fully sequenced, | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 520/520 (100 %) | 3 diff (99.5 %id) | |
AA064804 | .a | 1858 to 2045 | 188 to 1 | fully sequenced, | 188/188 (100 %) | 0 diff (100 %id) | |||
AA064881 | .a | 1705 to 1888 | 1 to 186 | fully sequenced, | 186/186 (100 %) | 0 diff (100 %id) | |||
AA083747 | .a | 1701 to 2037 | 1 to 339 | fully sequenced, | 339/339 (100 %) | 2 diff (99.5 %id) | |||
AA112884 | .a | 1913 to 2043 | 131 to 1 | fully sequenced, | 131/131 (100 %) | 0 diff (100 %id) | |||
AA171915 | .a | 1695 to 2006 | 1 to 312 | 312/415 (75 %) | 1 diff (99.8 %id) | ||||
AA233091 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .i | 317 to 800 | 1 to 484 | tiling clone, | 484/484 (100 %) | 2 diff (99.6 %id) | ||
AA243658 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .i | 1084 to 1520 | 437 to 1 | tiling clone, | 437/437 (100 %) | 0 diff (100 %id) | ||
AA236738 | germinal center B cell | .a | 1266 to 1611 | 346 to 1 | Submitted on the opposite strand | 346/346 (100 %) | 0 diff (100 %id) | ||
AA236913 | germinal center B cell | .e | 108 to 580 | 1 to 476 | Submitted on the opposite strand | 476/476 (100 %) | 8 diff (98.4 %id) | ||
AA258200 | germinal center B cell | .e | 108 to 491 | 1 to 384 | Submitted on the opposite strand | 384/384 (100 %) | 5 diff (98.7 %id) | ||
AA259013 | germinal center B cell | .a | 1191 to 1654 | 463 to 1 | Submitted on the opposite strand | 463/463 (100 %) | 1 diff (99.8 %id) | ||
AA287539 | germinal center B cell | .a | 1244 to 1650 | 407 to 5 | Submitted on the opposite strand | 403/407 (99 %) | 4 diff (99.1 %id) | ||
AA284419 | germinal center B cell | .a | 2797 to 3228 | 1 to 432 | 432/432 (100 %) | 1 diff (99.8 %id) | |||
AA292657 | germinal center B cell | .a | 3333 to 3720 | 388 to 1 | 388/388 (100 %) | 0 diff (100 %id) | |||
AA280612 | germinal center B cell | .e | 108 to 577 | 1 to 465 | Submitted on the opposite strand | 465/465 (100 %) | 8 diff (98.3 %id) | ||
AA282441 | germinal center B cell | .a | 1496 to 1646 | 151 to 1 | Submitted on the opposite strand | 151/151 (100 %) | 0 diff (100 %id) | ||
AA282216 | germinal center B cell | .e | 229 to 482 | 1 to 248 | Submitted on the opposite strand | 248/248 (100 %) | 10 diff (96.0 %id) | ||
AA282278 | germinal center B cell | .a | 1203 to 1612 | 410 to 1 | Submitted on the opposite strand | 410/410 (100 %) | 0 diff (100 %id) | ||
AA282325 | germinal center B cell | .b | 996 to 1476 | 481 to 1 | Submitted on the opposite strand | 481/481 (100 %) | 6 diff (98.8 %id) | ||
AA398463 | .c | 386 to 857 | 470 to 1 | fully sequenced, | 470/470 (100 %) | 1 diff (99.8 %id) | |||
AA401870 | .c | 259 to 447 | 8 to 194 | fully sequenced, | 187/194 (96 %) | 6 diff (97.0 %id) | |||
AA397764 | .c | 259 to 471 | 8 to 218 | 211/218 (96 %) | 6 diff (97.3 %id) | ||||
AA399557 | .c | 480 to 855 | 377 to 1 | 377/377 (100 %) | 1 diff (99.8 %id) | ||||
AA482640 | ovarian tumor, ovary | .b | 1107 to 1421 | 316 to 2 | Submitted on the opposite strand | 315/316 (99 %) | 1 diff (99.7 %id) | ||
AA430366 | ovarian tumor, ovary | .e | 107 to 379 | 1 to 273 | Submitted on the opposite strand | 273/273 (100 %) | 3 diff (99.0 %id) | ||
AA430415 | ovarian tumor, ovary | .a | 1421 to 1661 | 241 to 1 | Submitted on the opposite strand | 241/241 (100 %) | 0 diff (100 %id) | ||
AA460474 | .a | 1376 to 1655 | 281 to 1 | Submitted on the opposite strand | 281/287 (97 %) | 2 diff (99.4 %id) | |||
AA461089 | .e | 108 to 513 | 1 to 408 | Submitted on the opposite strand | 408/408 (100 %) | 7 diff (98.3 %id) | |||
AA461402 | .b | 1226 to 1515 | 290 to 1 | Submitted on the opposite strand | 290/290 (100 %) | 0 diff (100 %id) | |||
AA485351 | ovarian tumor, ovary | .e | 108 to 398 | 1 to 291 | Submitted on the opposite strand | 291/291 (100 %) | 1 diff (99.7 %id) | ||
AA485506 | ovarian tumor, ovary | .a | 1163 to 1611 | 449 to 1 | Submitted on the opposite strand | 449/449 (100 %) | 0 diff (100 %id) | ||
AA456500 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 1175 to 1471 | 297 to 1 | Submitted on the opposite strand | 297/297 (100 %) | 0 diff (100 %id) | ||
AA465438 | germinal center B cell | .a | 1279 to 1655 | 377 to 1 | Submitted on the opposite strand | 377/377 (100 %) | 0 diff (100 %id) | ||
AA481061 | germinal center B cell | .a | 2928 to 3369 | 442 to 1 | fully sequenced, | 442/442 (100 %) | 0 diff (100 %id) | ||
AA481118 | germinal center B cell | .a | 2763 to 2958 | 1 to 196 | fully sequenced, | 196/196 (100 %) | 0 diff (100 %id) | ||
AA491166 | germinal center B cell | .e | 273 to 595 | 341 to 23 | Submitted on the opposite strand | 319/341 (93 %) | 0 diff (100 %id) | ||
AA490398 | germinal center B cell | .a | 1409 to 1629 | 221 to 1 | Submitted on the opposite strand | 221/221 (100 %) | 3 diff (98.7 %id) | ||
AA664134 | lung | .a | 1256 to 1658 | 403 to 1 | 403/403 (100 %) | 0 diff (100 %id) | |||
AA682901 | schizophrenic brain S-11 frontal lobe | .a | 2087 to 2224 | 1 to 138 | Submitted on the opposite strand | 138/138 (100 %) | 0 diff (100 %id) | ||
AA600985 | adrenal adenoma, adrenal gland | .a | 1254 to 1655 | 402 to 1 | 402/404 (99 %) | 0 diff (100 %id) | |||
AA620850 | .a | 1281 to 1654 | 374 to 1 | 374/374 (100 %) | 0 diff (100 %id) | ||||
AA648500 | germinal center B cell | .a | 3935 to 4261 | 327 to 1 | 327/327 (100 %) | 0 diff (100 %id) | |||
AA805713 | germinal center B cell | .a | 3261 to 3720 | 488 to 29 | AAA | 460/460 (100 %) | 0 diff (100 %id) | ||
AA731262 | germinal center B cell | .a | 3357 to 3720 | 386 to 23 | AAA | 364/364 (100 %) | 0 diff (100 %id) | ||
AA876559 | metastatic prostate bone lesion | .a | 3182 to 3585 | 1 to 404 | 404/404 (100 %) | 0 diff (100 %id) | |||
AA746675 | alveolar rhabdomyosarcoma | .f | 61 to 398 | 338 to 5 | 334/340 (98 %) | 5 diff (98.6 %id) | |||
AA885548 | metastatic prostate bone lesion | .a | 7370 to 7555 | 226 to 41 | 186/231 (80 %) | 0 diff (100 %id) | |||
AA765979 | germinal center B cell | .a | 3918 to 4336 | 419 to 1 | 419/419 (100 %) | 0 diff (100 %id) | |||
AA809849 | germinal center B cell | .a | 3916 to 4261 | 346 to 1 | 346/346 (100 %) | 0 diff (100 %id) | |||
AA828320 | germinal center B cell | .a | 1198 to 1668 | 472 to 2 | 471/472 (99 %) | 2 diff (99.6 %id) | |||
AA836088 | germinal center B cell | .e | 189 to 408 | 1 to 220 | 220/220 (100 %) | 0 diff (100 %id) | |||
AA810135 | germinal center B cell | .a | 656 to 911 | 1 to 256 | Submitted on the opposite strand | 256/256 (100 %) | 0 diff (100 %id) | ||
AA847044 | ovary | .a | 621 to 804 | 185 to 2 | 184/188 (97 %) | 1 diff (99.5 %id) | |||
AA844118 | parathyroid gland, parathyroid tumor | .a | 3408 to 3720 | 323 to 11 | AAA | 313/313 (100 %) | 0 diff (100 %id) | ||
AA890280 | parathyroid gland, parathyroid tumor | .a | 3232 to 3720 | 502 to 14 | AAA | 489/489 (100 %) | 0 diff (100 %id) | ||
AA846746 | parathyroid gland, parathyroid tumor | .a | 3343 to 3722 | 392 to 13 | AAA | 380/380 (100 %) | 0 diff (100 %id) | ||
AA845909 | Spleen | .a | 1741 to 2047 | 307 to 1 | 307/307 (100 %) | 0 diff (100 %id) | |||
AI218747 | pooled | .e | 108 to 579 | 1 to 472 | Submitted on the opposite strand | 472/472 (100 %) | 0 diff (100 %id) | ||
AI014708 | pooled | .e | 108 to 553 | 1 to 446 | Submitted on the opposite strand | 446/446 (100 %) | 0 diff (100 %id) | ||
AI032076 | liver and spleen | .a | 1277 to 1654 | 378 to 1 | 378/378 (100 %) | 0 diff (100 %id) | |||
AI079891 | .e | 108 to 555 | 1 to 448 | Submitted on the opposite strand | 448/448 (100 %) | 0 diff (100 %id) | |||
AI052002 | parathyroid gland, parathyroid tumor | .e | 108 to 619 | 1 to 512 | Submitted on the opposite strand | 512/512 (100 %) | 0 diff (100 %id) | ||
AI052043 | parathyroid gland, parathyroid tumor | .e | 126 to 638 | 1 to 513 | Submitted on the opposite strand | 513/513 (100 %) | 0 diff (100 %id) | ||
AI078829 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .e | 108 to 561 | 1 to 454 | Submitted on the opposite strand | 454/454 (100 %) | 0 diff (100 %id) | ||
AI081925 | senescent fibroblast | .e | 108 to 557 | 1 to 450 | Submitted on the opposite strand | 450/450 (100 %) | 0 diff (100 %id) | ||
AI150715 | heart | .a | 1656 to 2043 | 388 to 1 | 388/388 (100 %) | 0 diff (100 %id) | |||
AI193910 | lung | .e | 108 to 488 | 1 to 381 | Submitted on the opposite strand | 381/381 (100 %) | 0 diff (100 %id) | ||
AI201317 | .e | 108 to 553 | 1 to 446 | Submitted on the opposite strand | 446/446 (100 %) | 0 diff (100 %id) | |||
AI220239 | pooled | .e | 108 to 420 | 1 to 313 | Submitted on the opposite strand | 313/313 (100 %) | 0 diff (100 %id) | ||
AI273352 | adenocarcinoma, colon | .a | 2561 to 3016 | 1 to 456 | Submitted on the opposite strand | 456/456 (100 %) | 0 diff (100 %id) | ||
AI340213 | 2 pooled tumors (clear cell type), Kidney | .a | 1604 to 2042 | 439 to 1 | 439/439 (100 %) | 0 diff (100 %id) | |||
AI494495 | anaplastic oligodendroglioma, brain | .e | 136 to 549 | 1 to 414 | Submitted on the opposite strand | 414/414 (100 %) | 0 diff (100 %id) | ||
AI307217 | 2 pooled tumors (clear cell type), Kidney | .b | 1087 to 1517 | 431 to 1 | 431/431 (100 %) | 3 diff (99.4 %id) | |||
AI424419 | Prostate | .e | 108 to 550 | 1 to 443 | Submitted on the opposite strand | 443/443 (100 %) | 0 diff (100 %id) | ||
AI380159 | brain, glioblastoma (pooled) | .a | 2945 to 3360 | 416 to 1 | 416/416 (100 %) | 0 diff (100 %id) | |||
AI393660 | pooled | .a | 1654 to 2041 | 388 to 1 | 388/388 (100 %) | 0 diff (100 %id) | |||
AI399870 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .e | 108 to 512 | 1 to 405 | Submitted on the opposite strand | 405/405 (100 %) | 0 diff (100 %id) | ||
AI417145 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .e | 108 to 621 | 1 to 514 | Submitted on the opposite strand | 514/514 (100 %) | 0 diff (100 %id) | ||
AI523837 | B-cell, chronic lymphotic leukemia | .a | 3255 to 3721 | 467 to 1 | 467/467 (100 %) | 0 diff (100 %id) | |||
AI523908 | B-cell, chronic lymphotic leukemia | .a | 3250 to 3721 | 472 to 1 | 472/472 (100 %) | 0 diff (100 %id) | |||
AI399688 | Prostate | .e | 108 to 618 | 1 to 511 | Submitted on the opposite strand | 511/511 (100 %) | 0 diff (100 %id) | ||
AI434596 | Kidney | .a | 7181 to 7664 | 484 to 1 | 484/484 (100 %) | 0 diff (100 %id) | |||
AI568914 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .e | 153 to 548 | 1 to 396 | Submitted on the opposite strand | 396/396 (100 %) | 0 diff (100 %id) | ||
AI566656 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .b | 1242 to 1519 | 281 to 4 | 278/281 (98 %) | 0 diff (100 %id) | |||
AI611305 | Prostate | .e | 108 to 310 | 1 to 203 | Submitted on the opposite strand | 203/203 (100 %) | 0 diff (100 %id) | ||
AI686385 | Prostate | .a | 5591 to 6161 | 571 to 1 | 571/571 (100 %) | 0 diff (100 %id) | |||
AI669558 | Prostate | .e | 108 to 474 | 1 to 367 | Submitted on the opposite strand | 367/367 (100 %) | 0 diff (100 %id) | ||
AI620486 | Prostate | .e | 108 to 555 | 1 to 448 | Submitted on the opposite strand | 448/448 (100 %) | 0 diff (100 %id) | ||
AI679643 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .b | 1049 to 1520 | 472 to 1 | 472/472 (100 %) | 0 diff (100 %id) | |||
AI680530 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .a | 7194 to 7667 | 477 to 4 | tiling clone, | 474/477 (99 %) | 0 diff (100 %id) | ||
AI911322 | pooled | .e | 153 to 619 | 1 to 467 | Submitted on the opposite strand | 467/467 (100 %) | 0 diff (100 %id) | ||
AI692862 | pooled | .e | 123 to 619 | 1 to 497 | Submitted on the opposite strand | 497/497 (100 %) | 0 diff (100 %id) | ||
AI660374 | thymus, pooled | .e | 108 to 575 | 1 to 468 | Submitted on the opposite strand | 468/468 (100 %) | 0 diff (100 %id) | ||
AI672892 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .e | 126 to 474 | 1 to 349 | Submitted on the opposite strand | 349/349 (100 %) | 0 diff (100 %id) | ||
AI797237 | pooled | .e | 108 to 632 | 1 to 525 | Submitted on the opposite strand | 525/525 (100 %) | 0 diff (100 %id) | ||
AI767075 | 2 pooled tumors (clear cell type), Kidney | .e | 167 to 505 | 1 to 339 | Submitted on the opposite strand | 339/339 (100 %) | 0 diff (100 %id) | ||
AI860548 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 7168 to 7663 | 496 to 1 | 496/496 (100 %) | 0 diff (100 %id) | |||
AW024378 | Kidney | .e | 108 to 632 | 1 to 525 | Submitted on the opposite strand | 525/525 (100 %) | 0 diff (100 %id) | ||
AW150842 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 3292 to 3720 | 429 to 1 | 429/429 (100 %) | 0 diff (100 %id) | |||
AW241456 | pooled germ cell tumors | .a | 3866 to 4317 | 452 to 1 | 452/452 (100 %) | 0 diff (100 %id) | |||
AW515557 | Kidney, renal cell tumor | .b | 1167 to 1566 | 435 to 36 | 399/435 (91 %) | 4 diff (99.1 %id) | |||
AW303349 | pooled | .e | 150 to 621 | 1 to 472 | Submitted on the opposite strand | 472/472 (100 %) | 0 diff (100 %id) | ||
AW305198 | brain, three pooled meningiomas | .a | 3357 to 3720 | 364 to 1 | 364/364 (100 %) | 0 diff (100 %id) | |||
AW328535 | cervix | .a | 638 to 1198 | 8 to 568 | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 561/568 (98 %) | 6 diff (99.0 %id) | ||
AW328536 | cervix | .a | 1557 to 2059 | 504 to 3 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 502/504 (99 %) | 0 diff (100 %id) | |
AW338693 | adenocarcinoma, Pancreas | .a | 3190 to 3721 | 532 to 1 | 532/532 (100 %) | 0 diff (100 %id) | |||
AW340701 | pooled | .e | 151 to 604 | 1 to 454 | Submitted on the opposite strand | 454/454 (100 %) | 0 diff (100 %id) | ||
AW403554 | lymph | .a | 1261 to 1654 | 415 to 22 | AAA | Submitted on the opposite strand | 394/394 (100 %) | 0 diff (100 %id) | |
BU430411 | lymph | .a | 1141 to 1654 | 534 to 21 | AAA | Submitted on the opposite strand | 514/514 (100 %) | 0 diff (100 %id) | |
BU431107 | lymph | .a | 3478 to 3720 | 285 to 41 | AAA | Submitted on the opposite strand | 245/245 (100 %) | 4 diff (98.4 %id) | |
AW502124 | lymph | .a | 7266 to 7664 | 432 to 34 | Submitted on the opposite strand | 399/432 (92 %) | 0 diff (100 %id) | ||
AW502224 | lymph | .a | 7165 to 7664 | 533 to 34 | Submitted on the opposite strand | 500/533 (93 %) | 0 diff (100 %id) | ||
AW505189 | lymph | .a | 3428 to 3644 | 224 to 8 | Submitted on the opposite strand | 217/224 (96 %) | 0 diff (100 %id) | ||
AW505601 | lymph | .a | 3304 to 3677 | 381 to 8 | Submitted on the opposite strand | 374/381 (98 %) | 0 diff (100 %id) | ||
CF137953 | lymph | .a | 3334 to 3725 | 432 to 41 | AAA | Submitted on the opposite strand | 392/392 (100 %) | 0 diff (100 %id) | |
CF138090 | lymph | .a | 3014 to 3563 | 1 to 550 | 550/550 (100 %) | 5 diff (99.1 %id) | |||
CF142916 | lymph | .a | 2232 to 2624 | 8 to 400 | 393/400 (98 %) | 6 diff (98.5 %id) | |||
CF143506 | lymph | .a | 7172 to 7664 | 526 to 34 | Submitted on the opposite strand | 493/526 (93 %) | 0 diff (100 %id) | ||
CF143508 | lymph | .a | 7183 to 7664 | 515 to 34 | Submitted on the opposite strand | 482/515 (93 %) | 0 diff (100 %id) | ||
BE218866 | carcinoid, lung | .l | 1 to 531 | 531 to 1 | T10M S11P P14Q | tiling clone, | 531/531 (100 %) | 4 diff (99.3 %id) | |
BE551293 | carcinoid, lung | .a | 1147 to 1654 | 1 to 508 | AAA | Submitted on the opposite strand | 508/508 (100 %) | 5 diff (99.1 %id) | |
CB046495 | 2 pooled tumors (clear cell type), Kidney | .a | 1340 to 1654 | 345 to 31 | AAA | Submitted on the opposite strand | 315/315 (100 %) | 3 diff (99.1 %id) | |
BF476058 | Prostate | .a | 7349 to 7663 | 315 to 1 | 315/315 (100 %) | 0 diff (100 %id) | |||
BE645008 | pooled | .a | 3830 to 4317 | 488 to 1 | 488/488 (100 %) | 0 diff (100 %id) | |||
CB051815 | leiomyosarcoma, soft tissue | .d | 526 to 1160 | 636 to 3 | tiling clone, | 634/636 (99 %) | 0 diff (100 %id) | ||
BE676789 | B-cell, chronic lymphotic leukemia | .g | 1 to 448 | 1 to 448 | exact | tiling clone, AAA | Submitted on the opposite strand | 448/448 (100 %) | 8 diff (98.3 %id) |
BF940637 | fibrotheoma, ovary | .e | 126 to 541 | 1 to 416 | Submitted on the opposite strand | 416/416 (100 %) | 0 diff (100 %id) | ||
BF940742 | fibrotheoma, ovary | .e | 108 to 611 | 1 to 504 | Submitted on the opposite strand | 504/504 (100 %) | 0 diff (100 %id) | ||
BF115222 | fibrotheoma, ovary | .e | 108 to 621 | 1 to 514 | Submitted on the opposite strand | 514/514 (100 %) | 0 diff (100 %id) | ||
BE613684 | leiomyosarcoma, uterus | .a | 786 to 1357 | 1 to 573 | 573/573 (100 %) | 1 diff (99.9 %id) | |||
BE614392 | leiomyosarcoma, uterus | .a | 2920 to 3664 | 753 to 7 | 747/761 (98 %) | 0 diff (100 %id) | |||
BE888553 | leiomyosarcoma, uterus | .a | 6970 to 7659 | 1 to 686 | tiling clone, | 686/686 (100 %) | 7 diff (99.0 %id) | ||
BF382427 | brain, primitive neuroectoderm | .a | 3004 to 3353 | 257 to 621 | 490/725 (67 %) | 64 diff (91.2 %id) | |||
BF214646 | bone marrow, from acute myelogenous leukemia | .c | 276 to 965 | 1 to 683 | 683/870 (78 %) | 21 diff (97.6 %id) | |||
BC023994 | Bone marrow, acute myelogenous leukemia | .a | 2089 to 3382 | 4 to 1297 | available from MGC, AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 1294/1294 (100 %) | 1 diff (100.0 %id) | |
BF700960 | brain, primitive neuroectoderm | .b | 956 to 1569 | 1 to 612 | 612/865 (70 %) | 13 diff (98.5 %id) | |||
BG036029 | adenocarcinoma, cell line, Liver | .a | 2817 to 3608 | 1 to 791 | 791/908 (87 %) | 20 diff (97.8 %id) | |||
BG165164 | hypernephroma, cell line, Kidney | .a | 2470 to 3099 | 1 to 630 | 630/630 (100 %) | 0 diff (100 %id) | |||
BG286531 | bladder, transitional cell papilloma, cell line | .a | 3140 to 3926 | 1 to 771 | 771/882 (87 %) | 40 diff (95.5 %id) | |||
BG288301 | bladder, transitional cell papilloma, cell line | .a | 1146 to 1654 | 1 to 509 | AAA | 509/509 (100 %) | 0 diff (100 %id) | ||
BG283593 | adenocarcinoma, cell line, Prostate | .a | 705 to 1455 | 1 to 758 | 758/1212 (62 %) | 12 diff (99.1 %id) | |||
BG434154 | placenta | .a | 749 to 1463 | 1 to 712 | 712/712 (100 %) | 3 diff (99.6 %id) | |||
BG530089 | embryonal carcinoma, testis | .a | 5543 to 6180 | 1 to 639 | 639/819 (78 %) | 12 diff (98.6 %id) | |||
BG569738 | lung | .a | 3071 to 3783 | 1 to 711 | 711/711 (100 %) | 18 diff (97.5 %id) | |||
BC014977 | Skin, melanotic melanoma, high MDR. | .a | 29 to 1654 | 1 to 1626 | available from MGC, AAA | 1626/1626 (100 %) | 0 diff (100 %id) | ||
BG770400 | melanotic melanoma, high MDR (cell line), skin | .e | 66 to 839 | 1 to 772 | Q168K T169P K170N W171G A172R ... | tiling clone, available from MGC, | 772/906 (85 %) | 15 diff (98.4 %id) | |
BC022825 | Pancreas, epithelioid carcinoma | .e | 127 to 834 | 1 to 708 | exact | tiling clone, available from MGC, AAA | 708/708 (100 %) | 1 diff (99.9 %id) | |
BI194214 | epithelioid carcinoma cell line, Pancreas | .e | 126 to 834 | 1 to 716 | R99L A100R R101S A102G A103C ... | available from MGC, | 716/788 (90 %) | 26 diff (96.8 %id) | |
BM452575 | lymph, lymphoma, cell line | .a | 1984 to 2898 | 1 to 923 | 923/1055 (87 %) | 17 diff (98.4 %id) | |||
BM475090 | duodenal adenocarcinoma, cell line, small intestine | .a | 2605 to 3340 | 1 to 746 | 746/1027 (72 %) | 17 diff (98.4 %id) | |||
BM511837 | insulinoma, Pancreas | .a | 1043 to 1654 | 627 to 16 | AAA | 612/612 (100 %) | 0 diff (100 %id) | ||
BM512058 | insulinoma, Pancreas | .a | 237 to 765 | 1 to 532 | 532/532 (100 %) | 5 diff (99.1 %id) | |||
BM547021 | brain, hippocampus | .a | 2989 to 3721 | 1 to 733 | 733/1088 (67 %) | 2 diff (99.9 %id) | |||
BM807325 | duodenal adenocarcinoma, cell line, small intestine | .a | 2554 to 3385 | 1 to 844 | 844/920 (91 %) | 27 diff (97.1 %id) | |||
BQ267507 | insulinoma, Pancreas | .b | 936 to 1514 | 594 to 16 | tiling clone, AAA | 579/579 (100 %) | 0 diff (100 %id) | ||
BQ270426 | insulinoma, Pancreas | .b | 1 to 427 | 1 to 427 | tiling clone, | 427/427 (100 %) | 4 diff (99.1 %id) | ||
BQ271176 | Pancreas, Purified pancreatic islet | .h | 1692 to 2261 | 575 to 6 | tiling clone, | 570/575 (99 %) | 0 diff (100 %id) | ||
BQ271475 | Pancreas, Purified pancreatic islet | .h | 193 to 777 | 1 to 585 | exact | tiling clone, | 585/585 (100 %) | 0 diff (100 %id) | |
BQ008391 | Chondrosarcoma, Left Pelvis | .a | 3312 to 3720 | 427 to 19 | AAA | 409/409 (100 %) | 0 diff (100 %id) | ||
BQ030087 | lung, Metastatic Chondrosarcoma | .a | 3181 to 3720 | 558 to 19 | AAA | 540/540 (100 %) | 0 diff (100 %id) | ||
BQ030396 | lung, Metastatic Chondrosarcoma | .a | 3467 to 3720 | 272 to 19 | AAA | 254/254 (100 %) | 0 diff (100 %id) | ||
CB215356 | normal endometrium, late proliferativephase, cycle day 13, uterus | .a | 1581 to 2238 | 1 to 658 | 658/658 (100 %) | 0 diff (100 %id) | |||
BQ549076 | insulinoma, Pancreas | .a | 3637 to 4187 | 1 to 551 | 551/551 (100 %) | 5 diff (99.1 %id) | |||
BQ549562 | insulinoma, Pancreas | .a | 3864 to 4482 | 634 to 16 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 619/619 (100 %) | 0 diff (100 %id) | |
CK826206 | insulinoma, Pancreas | .a | 3637 to 4115 | 1 to 479 | 479/479 (100 %) | 5 diff (99.0 %id) | |||
BQ582263 | insulinoma, Pancreas | .b | 910 to 1498 | 590 to 1 | fully sequenced, | 590/590 (100 %) | 3 diff (99.5 %id) | ||
BQ630995 | insulinoma, Pancreas | .b | 427 to 940 | 1 to 515 | tiling clone, fully sequenced, | 487/487 (100 %) | 15 diff (97.0 %id) | ||
BU071876 | insulinoma, Pancreas | .a | 4528 to 5076 | 1 to 551 | tiling clone, | 551/551 (100 %) | 7 diff (98.8 %id) | ||
BU073395 | insulinoma, Pancreas | .a | 5592 to 6179 | 588 to 1 | 588/588 (100 %) | 1 diff (99.9 %id) | |||
BQ216001 | embryonal carcinoma, cell line, testis | .a | 2468 to 3248 | 1 to 788 | 788/836 (94 %) | 14 diff (98.4 %id) | |||
BU169536 | melanotic melanoma, skin | .a | 2508 to 3360 | 1 to 856 | 856/863 (99 %) | 7 diff (99.2 %id) | |||
BU194281 | bone marrow, from acute myelogenous leukemia | .k | 1 to 634 | 34 to 674 | exact | tiling clone, | 641/819 (78 %) | 18 diff (97.9 %id) | |
BU784993 | Pancreas, Purified pancreatic islet | .a | 5530 to 6163 | 634 to 1 | 634/634 (100 %) | 2 diff (99.7 %id) | |||
BU785262 | Pancreas, Purified pancreatic islet | .a | 4501 to 5123 | 10 to 643 | tiling clone, | 634/643 (98 %) | 6 diff (99.1 %id) | ||
CX782414 | human embryonic stem cells | .a | 2981 to 3720 | 767 to 28 | AAA | 740/740 (100 %) | 0 diff (100 %id) | ||
CX782498 | human embryonic stem cells | .a | 1534 to 2399 | 1 to 866 | 866/866 (100 %) | 0 diff (100 %id) | |||
CX788354 | human embryonic stem cells | .a | 1094 to 1902 | 1 to 809 | 809/809 (100 %) | 0 diff (100 %id) | |||
DR157809 | human embryonic stem cells differentiated toan early endodermal cell type | .j-u | 467 to 1222 | 1 to 756 | exact | tiling clone, | 756/756 (100 %) | 1 diff (99.9 %id) | |
TI_45216427 | .a | 231 to 1025 | 129 to 924 | 796/924 (86 %) | 19 diff (98.0 %id) | ||||
TI_44350679 | .e | 33 to 782 | 80 to 822 | R119L P128R Q129K A130R G131E ... | 743/822 (90 %) | 12 diff (98.6 %id) | |||
TI_44344980 | .e | 269 to 796 | 85 to 606 | 522/606 (86 %) | 6 diff (99.1 %id) | ||||
TI_44346520 | .a | 170 to 963 | 79 to 886 | AAA | 806/916 (87 %) | 45 diff (95.1 %id) | |||
TI_57190434 | .a | 3294 to 3720 | 51 to 477 | AAA | 427/427 (100 %) | 1 diff (99.8 %id) | |||
TI_57230162 | .j-u | 486 to 1136 | 124 to 778 | exact | 655/659 (99 %) | 8 diff (98.8 %id) | |||
TI_59382006 | .e | 163 to 736 | 257 to 865 | 744/895 (83 %) | 59 diff (93.5 %id) | ||||
TI_59382176 | .e | 20 to 550 | 128 to 668 | 541/729 (74 %) | 18 diff (97.6 %id) | ||||
TI_59393025 | .a | 3194 to 3721 | 89 to 616 | AAA | 528/605 (87 %) | 4 diff (99.4 %id) | |||
DC428181 | .b | 1281 to 1834 | 1 to 555 | tiling clone, | 555/555 (100 %) | 2 diff (99.7 %id) | |||
CB112343 | Liver | .a | 2251 to 2738 | 1 to 488 | 488/488 (100 %) | 0 diff (100 %id) | |||
CB136286 | Liver | .a | 1668 to 2349 | 1 to 682 | 682/682 (100 %) | 0 diff (100 %id) | |||
CB135681 | Liver | .a | 1619 to 2028 | 410 to 1 | Submitted on the opposite strand | 410/459 (89 %) | 4 diff (99.2 %id) | ||
CB144162 | Liver | .a | 1074 to 1372 | 1 to 299 | 299/299 (100 %) | 0 diff (100 %id) | |||
CB143812 | Liver | .a | 828 to 1224 | 1 to 397 | 397/397 (100 %) | 0 diff (100 %id) | |||
CB162241 | Liver | .a | 2977 to 3593 | 1 to 617 | 617/617 (100 %) | 0 diff (100 %id) | |||
CB164319 | Liver | .a | 755 to 1363 | 1 to 609 | 609/609 (100 %) | 0 diff (100 %id) | |||
CB163775 | Liver | .a | 755 to 1299 | 1 to 545 | 545/545 (100 %) | 0 diff (100 %id) | |||
CB160034 | Liver | .a | 2563 to 3095 | 1 to 533 | 533/533 (100 %) | 0 diff (100 %id) | |||
CB160160 | Liver | .a | 3282 to 3722 | 487 to 47 | AAA | Submitted on the opposite strand | 441/441 (100 %) | 3 diff (99.4 %id) | |
BP428547 | .a | 1947 to 2330 | 384 to 1 | 384/384 (100 %) | 0 diff (100 %id) | ||||
BY995519 | .a | 345 to 1016 | 20 to 691 | 672/691 (97 %) | 6 diff (99.2 %id) | ||||
DB321683 | .a | 7135 to 7666 | 533 to 1 | 533/533 (100 %) | 2 diff (99.7 %id) | ||||
DA650581 | .a | 1013 to 1563 | 2 to 552 | capped | 551/551 (100 %) | 0 diff (100 %id) | |||
AU253373 | neuroblastoma | .a | 1664 to 2346 | 1 to 683 | 683/683 (100 %) | 0 diff (100 %id) | |||
AU253374 | neuroblastoma | .a | 3017 to 3717 | 700 to 4 | 697/700 (99 %) | 0 diff (100 %id) | |||
NM_178812.3 | .a | 1 to 7667 | 1 to 7667 | exact | RefSeq, | 7667/7667 (100 %) | 0 diff (100 %id) | ||
DC424433 | .b | 1062 to 1802 | 1 to 743 | 743/747 (99 %) | 7 diff (99.1 %id) | ||||
DC427246 | .b | 3065 to 3580 | 518 to 1 | tiling clone, | 518/526 (98 %) | 13 diff (97.6 %id) | |||
DC371363 | .b | 952 to 1513 | 1 to 562 | 562/562 (100 %) | 1 diff (99.9 %id) | ||||
DC375002 | brain | .b | 1127 to 1691 | 1 to 566 | 566/566 (100 %) | 1 diff (99.9 %id) | |||
DA819687 | .a | 615 to 1182 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | |||
DC379513 | pericardium | .b | 1248 to 1788 | 1 to 541 | tiling clone, | 541/541 (100 %) | 2 diff (99.7 %id) | ||
DA876299 | Prostate | .j-u | 1 to 569 | 2 to 570 | tiling clone, capped | 569/569 (100 %) | 0 diff (100 %id) | ||
BM752308 | Ascites, stomach | .a | 841 to 1198 | 1 to 358 | 358/358 (100 %) | 0 diff (100 %id) | |||
BM785722 | Ascites, stomach | .a | 842 to 1505 | 1 to 662 | 662/662 (100 %) | 4 diff (99.4 %id) | |||
BM828904 | Ascites, stomach | .a | 1197 to 1389 | 1 to 193 | 193/193 (100 %) | 0 diff (100 %id) | |||
BM854886 | stomach | .a | 5664 to 6162 | 1 to 499 | 499/499 (100 %) | 0 diff (100 %id) | |||
TI_1948157042 | .a | 322 to 1261 | 127 to 1059 | fully sequenced, | 933/1059 (88 %) | 25 diff (97.7 %id) | |||
TI_1948157043 | .a | 1231 to 2076 | 983 to 130 | fully sequenced, | 854/983 (86 %) | 5 diff (99.5 %id) | |||
TI_1948157188 | .a | 322 to 1242 | 131 to 1044 | fully sequenced, AAA | 914/1044 (87 %) | 23 diff (97.8 %id) | |||
TI_1948157189 | .a | 1212 to 2076 | 997 to 129 | fully sequenced, | 869/997 (87 %) | 10 diff (99.0 %id) | |||
TI_1948157354 | .a | 322 to 1261 | 129 to 1053 | fully sequenced, AAA | 925/1053 (87 %) | 25 diff (97.7 %id) | |||
TI_1948157355 | .a | 1231 to 2076 | 972 to 126 | fully sequenced, | 847/972 (87 %) | 5 diff (99.5 %id) | |||
TI_1948207519 | .a | 322 to 1284 | 132 to 1093 | fully sequenced, AAA | 962/1093 (88 %) | 29 diff (97.4 %id) | |||
TI_1948207520 | .a | 1267 to 2076 | 946 to 127 | fully sequenced, | 820/946 (86 %) | 18 diff (98.1 %id) | |||
DA922528 | small intestine | .a | 1723 to 2283 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DA941239 | Spleen | .a | 712 to 1302 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
DB003674 | breast, tumor tissue | .a | 1652 to 2195 | 2 to 545 | capped | 544/544 (100 %) | 0 diff (100 %id) | ||
DN997217 | breast cancer, Mammary gland (cancer tissue) | .e | 207 to 716 | 9 to 518 | 510/518 (98 %) | 6 diff (98.9 %id) | |||
BM149508 | leukopheresis | .e | 1 to 503 | 1 to 503 | tiling clone, | 503/503 (100 %) | 4 diff (99.3 %id) | ||
DB014305 | esophageal, tumor tissue | .a | 1697 to 2151 | 2 to 456 | capped | 455/455 (100 %) | 0 diff (100 %id) | ||
DB102839 | thymus | .a | 3629 to 4178 | 2 to 551 | capped | 550/550 (100 %) | 0 diff (100 %id) | ||
DC405675 | thymus | .c | 232 to 819 | 1 to 588 | 588/588 (100 %) | 0 diff (100 %id) | |||
DB115881 | thymus | .j-u | 95 to 635 | 2 to 543 | capped | 542/542 (100 %) | 1 diff (99.9 %id) | ||
DB123015 | thymus | .d | 1 to 569 | 2 to 570 | tiling clone, capped | 569/569 (100 %) | 1 diff (99.9 %id) | ||
DB123575 | thymus | .a | 1296 to 1905 | 2 to 611 | capped | 610/610 (100 %) | 0 diff (100 %id) | ||
TI_149274710 | .a | 1613 to 2059 | 518 to 73 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 446/1091 (40 %) | 4 diff (99.7 %id) | ||
TI_149279438 | .a | 1391 to 2033 | 91 to 733 | Submitted on the opposite strand | 643/764 (84 %) | 7 diff (99.1 %id) | |||
TI_149280748 | .a | 2899 to 3720 | 903 to 83 | AAA | 821/821 (100 %) | 15 diff (98.2 %id) | |||
TI_149284742 | .a | 2036 to 2623 | 665 to 78 | AAA | 588/1062 (55 %) | 10 diff (99.1 %id) | |||
TI_149310391 | .c | 244 to 875 | 698 to 66 | tiling clone, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 633/962 (65 %) | 6 diff (99.4 %id) | ||
TI_154021762 | .a | 2676 to 3378 | 791 to 89 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 703/704 (99 %) | 3 diff (99.6 %id) | ||
TI_154026851 | .a | 1290 to 2059 | 819 to 55 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 765/1207 (63 %) | 15 diff (98.8 %id) | ||
TI_154027902 | .a | 7071 to 7663 | 697 to 99 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 599/694 (86 %) | 69 diff (90.1 %id) | ||
TI_154048174 | .a | 2926 to 3720 | 881 to 88 | AAA | 794/1013 (78 %) | 10 diff (99.1 %id) | |||
TI_154136722 | .e | 97 to 647 | 14 to 562 | Submitted on the opposite strand | 549/1309 (41 %) | 6 diff (99.6 %id) | |||
TI_154140274 | .a | 1088 to 1654 | 682 to 115 | AAA | Submitted on the opposite strand | 568/571 (99 %) | 10 diff (98.3 %id) | ||
TI_154149157 | .a | 2178 to 2778 | 66 to 683 | 618/750 (82 %) | 50 diff (93.4 %id) | ||||
TI_154149652 | .a | 1073 to 1593 | 79 to 599 | 521/521 (100 %) | 7 diff (98.7 %id) | ||||
TI_154151779 | .a | 1072 to 1654 | 675 to 93 | AAA | Submitted on the opposite strand | 583/661 (88 %) | 5 diff (99.3 %id) | ||
TI_154153350 | .a | 1885 to 2493 | 80 to 688 | 609/609 (100 %) | 0 diff (100 %id) | ||||
TI_154155582 | .a | 3097 to 3545 | 78 to 526 | 449/449 (100 %) | 0 diff (100 %id) | ||||
TI_154157482 | .a | 7213 to 7664 | 560 to 109 | Submitted on the opposite strand | 452/478 (94 %) | 0 diff (100 %id) | |||
TI_154157605 | .a | 7075 to 7664 | 692 to 104 | AAA | Submitted on the opposite strand | 589/616 (95 %) | 0 diff (100 %id) | ||
TI_154161746 | .a | 3089 to 3644 | 633 to 78 | Submitted on the opposite strand | 556/559 (99 %) | 5 diff (99.2 %id) | |||
TI_154162364 | .a | 3138 to 3677 | 616 to 78 | Submitted on the opposite strand | 539/539 (100 %) | 16 diff (97.1 %id) | |||
TI_154164461 | .a | 850 to 1598 | 78 to 818 | 741/900 (82 %) | 12 diff (98.7 %id) | ||||
TI_154167676 | .a | 3282 to 3725 | 556 to 113 | AAA | Submitted on the opposite strand | 444/444 (100 %) | 0 diff (100 %id) | ||
TI_154167874 | .a | 3021 to 3717 | 93 to 798 | 706/869 (81 %) | 14 diff (98.4 %id) | ||||
TI_154174059 | .a | 2232 to 2746 | 82 to 603 | 522/674 (77 %) | 26 diff (96.2 %id) | ||||
TI_154174912 | .a | 7073 to 7664 | 696 to 104 | Submitted on the opposite strand | 593/693 (85 %) | 0 diff (100 %id) | |||
TI_154174960 | .a | 7067 to 7664 | 715 to 114 | Submitted on the opposite strand | 602/691 (87 %) | 0 diff (100 %id) | |||
TI_154180875 | .a | 1580 to 2414 | 73 to 909 | 837/839 (99 %) | 13 diff (98.5 %id) | ||||
TI_157609014 | .e | 97 to 643 | 50 to 594 | Submitted on the opposite strand | 545/601 (90 %) | 6 diff (99.1 %id) | |||
TI_159715093 | .a | 819 to 1654 | 924 to 93 | AAA | 830/1041 (79 %) | 19 diff (98.2 %id) | |||
TI_227712813 | .a | 898 to 1684 | 868 to 88 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 781/1046 (74 %) | 23 diff (97.9 %id) | ||
DB179945 | kidney, tumor tissue | .a | 1413 to 1943 | 2 to 532 | capped | 531/531 (100 %) | 0 diff (100 %id) | ||
BU678847 | lung, Primary Lung Epithelial Cells | .a | 1391 to 2033 | 26 to 668 | Submitted on the opposite strand | 643/666 (96 %) | 7 diff (99.0 %id) | ||
BU688700 | lung, Primary Lung Epithelial Cells | .c | 259 to 866 | 615 to 9 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 607/623 (97 %) | 0 diff (100 %id) | |
BU607394 | Human Lung Epithelial cells, lung | .a | 2654 to 3360 | 719 to 13 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 707/707 (100 %) | 2 diff (99.8 %id) | |
CB241994 | Human Lung Epithelial cells, lung | .a | 2947 to 3720 | 792 to 19 | AAA | 774/774 (100 %) | 0 diff (100 %id) | ||
BM662963 | eye, RPE and Choroid | .a | 3038 to 3720 | 700 to 18 | AAA | 683/683 (100 %) | 2 diff (99.8 %id) | ||
BQ184276 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 9 to 682 | AAA | Submitted on the opposite strand | 674/682 (98 %) | 6 diff (99.2 %id) | |
BQ185986 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 699 to 25 | AAA | Submitted on the opposite strand | 675/685 (98 %) | 3 diff (99.6 %id) | |
BQ187335 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3399 to 3720 | 346 to 25 | AAA | Submitted on the opposite strand | 322/323 (99 %) | 13 diff (96.0 %id) | |
CK300653 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 9 to 682 | AAA | Submitted on the opposite strand | 674/682 (98 %) | 6 diff (99.2 %id) | |
BM725072 | eye, fetal eye | .a | 2081 to 2801 | 1 to 721 | 721/721 (100 %) | 0 diff (100 %id) | |||
BU741972 | eye, fetal eye | .a | 3072 to 3720 | 667 to 19 | AAA | 649/649 (100 %) | 0 diff (100 %id) | ||
CA413238 | Chondrosarcoma Grade II, Left Pelvis | .a | 2992 to 3720 | 747 to 19 | AAA | 729/729 (100 %) | 1 diff (99.9 %id) | ||
BU625225 | cell lines, Enchondroma | .a | 2984 to 3720 | 755 to 19 | AAA | 737/737 (100 %) | 0 diff (100 %id) | ||
BQ774869 | Bone, Human Chondrosarcoma Cell Line | .a | 835 to 1623 | 797 to 9 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 789/797 (98 %) | 2 diff (99.8 %id) | |
BU619155 | Cell Line, Chondrosarcoma | .a | 7171 to 7658 | 506 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 488/488 (100 %) | 0 diff (100 %id) | |
TI_153949268 | .j-u | 478 to 1266 | 85 to 862 | Y25X | tiling clone, | 778/1001 (77 %) | 25 diff (97.6 %id) | ||
DC420312 | uterus | .f | 1 to 486 | 1 to 486 | tiling clone, | 486/486 (100 %) | 0 diff (100 %id) | ||
DB294613 | .a | 2043 to 2863 | 2 to 823 | capped | 822/828 (99 %) | 9 diff (99.0 %id) | |||
DB384757 | .a | 4352 to 4901 | 547 to 1 | tiling clone, | 547/548 (99 %) | 19 diff (96.6 %id) | |||
AL117594 | brain | .a | 828 to 1224 | 1 to 397 | available from DKFZ, AAA | Suspected internal deletion, this clone was ignored | 397/397 (100 %) | 0 diff (100 %id) | |
BE075665 | breast | .a | 2977 to 3593 | 1 to 617 | 617/617 (100 %) | 0 diff (100 %id) | |||
BQ318898 | colon | .a | 755 to 1363 | 1 to 609 | 609/609 (100 %) | 0 diff (100 %id) | |||
H38615 | eye, retina | .a | 755 to 1299 | 1 to 545 | 545/545 (100 %) | 0 diff (100 %id) | |||
H38857 | eye, retina | .a | 2563 to 3095 | 1 to 533 | 533/533 (100 %) | 0 diff (100 %id) | |||
AA017595 | eye, retina | .a | 3282 to 3722 | 487 to 47 | 441/441 (100 %) | 3 diff (99.4 %id) | |||
AA021218 | eye, retina | .a | 1947 to 2330 | 384 to 1 | 384/384 (100 %) | 0 diff (100 %id) | |||
AA021624 | eye, retina | .a | 345 to 1016 | 20 to 691 | 672/691 (97 %) | 6 diff (99.2 %id) | |||
AA046291 | eye, retina | .a | 7135 to 7666 | 533 to 1 | 533/533 (100 %) | 2 diff (99.7 %id) | |||
AA053797 | eye, retina | .a | 1013 to 1563 | 2 to 552 | 551/551 (100 %) | 0 diff (100 %id) | |||
AI912830 | Kidney | .a | 1664 to 2346 | 1 to 683 | 683/683 (100 %) | 0 diff (100 %id) | |||
BC001815 | Lymph, Burkitt lymphoma | .a | 3017 to 3717 | 700 to 4 | available from MGC, AAA | Suspected internal deletion, this clone was ignored | 697/700 (99 %) | 0 diff (100 %id) | |
BC009324 | Brain, neuroblastoma | .a | 1 to 7667 | 1 to 7667 | RefSeq, available from MGC, AAA | Suspected internal deletion, this clone was ignored | 7667/7667 (100 %) | 0 diff (100 %id) | |
TI_154154523 | .b | 1062 to 1802 | 1 to 743 | AAA | This clone was ignored | 743/747 (99 %) | 7 diff (99.1 %id) | ||
DC427246 | .b | 3065 to 3580 | 518 to 1 | tiling clone, | 518/526 (98 %) | 13 diff (97.6 %id) | |||
DC371363 | .b | 952 to 1513 | 1 to 562 | 562/562 (100 %) | 1 diff (99.9 %id) | ||||
DC375002 | brain | .b | 1127 to 1691 | 1 to 566 | 566/566 (100 %) | 1 diff (99.9 %id) | |||
DA819687 | .a | 615 to 1182 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | |||
DC379513 | pericardium | .b | 1248 to 1788 | 1 to 541 | tiling clone, | 541/541 (100 %) | 2 diff (99.7 %id) | ||
DA876299 | Prostate | .j-u | 1 to 569 | 2 to 570 | tiling clone, capped | 569/569 (100 %) | 0 diff (100 %id) | ||
BM752308 | Ascites, stomach | .a | 841 to 1198 | 1 to 358 | 358/358 (100 %) | 0 diff (100 %id) | |||
BM752308 | Ascites, stomach | .a | 841 to 1198 | 1 to 358 | 358/358 (100 %) | 0 diff (100 %id) | |||
BM785722 | Ascites, stomach | .a | 842 to 1505 | 1 to 662 | 662/662 (100 %) | 4 diff (99.4 %id) | |||
BM785722 | Ascites, stomach | .a | 842 to 1505 | 1 to 662 | 662/662 (100 %) | 4 diff (99.4 %id) | |||
BM828904 | Ascites, stomach | .a | 1197 to 1389 | 1 to 193 | 193/193 (100 %) | 0 diff (100 %id) | |||
BM828904 | Ascites, stomach | .a | 1197 to 1389 | 1 to 193 | 193/193 (100 %) | 0 diff (100 %id) | |||
BM854886 | stomach | .a | 5664 to 6162 | 1 to 499 | 499/499 (100 %) | 0 diff (100 %id) | |||
TI_1948157042 | .a | 322 to 1261 | 127 to 1059 | fully sequenced, | 933/1059 (88 %) | 25 diff (97.7 %id) | |||
TI_1948157043 | .a | 1231 to 2076 | 983 to 130 | fully sequenced, | 854/983 (86 %) | 5 diff (99.5 %id) | |||
TI_1948157188 | .a | 322 to 1242 | 131 to 1044 | fully sequenced, AAA | 914/1044 (87 %) | 23 diff (97.8 %id) | |||
TI_1948157189 | .a | 1212 to 2076 | 997 to 129 | fully sequenced, | 869/997 (87 %) | 10 diff (99.0 %id) | |||
TI_1948157354 | .a | 322 to 1261 | 129 to 1053 | fully sequenced, AAA | 925/1053 (87 %) | 25 diff (97.7 %id) | |||
TI_1948157355 | .a | 1231 to 2076 | 972 to 126 | fully sequenced, | 847/972 (87 %) | 5 diff (99.5 %id) | |||
TI_1948207519 | .a | 322 to 1284 | 132 to 1093 | fully sequenced, AAA | 962/1093 (88 %) | 29 diff (97.4 %id) | |||
TI_1948207520 | .a | 1267 to 2076 | 946 to 127 | fully sequenced, | 820/946 (86 %) | 18 diff (98.1 %id) | |||
DA922528 | small intestine | .a | 1723 to 2283 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DA941239 | Spleen | .a | 712 to 1302 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
DB003674 | breast, tumor tissue | .a | 1652 to 2195 | 2 to 545 | capped | 544/544 (100 %) | 0 diff (100 %id) | ||
DN997217 | breast cancer, Mammary gland (cancer tissue) | .e | 207 to 716 | 9 to 518 | 510/518 (98 %) | 6 diff (98.9 %id) | |||
DN997217 | breast cancer, Mammary gland (cancer tissue) | .e | 207 to 716 | 9 to 518 | 510/518 (98 %) | 6 diff (98.9 %id) | |||
BM149508 | leukopheresis | .e | 1 to 503 | 1 to 503 | tiling clone, | 503/503 (100 %) | 4 diff (99.3 %id) | ||
DB014305 | esophageal, tumor tissue | .a | 1697 to 2151 | 2 to 456 | capped | 455/455 (100 %) | 0 diff (100 %id) | ||
DB102839 | thymus | .a | 3629 to 4178 | 2 to 551 | capped | 550/550 (100 %) | 0 diff (100 %id) | ||
DC405675 | thymus | .c | 232 to 819 | 1 to 588 | 588/588 (100 %) | 0 diff (100 %id) | |||
DB115881 | thymus | .j-u | 95 to 635 | 2 to 543 | capped | 542/542 (100 %) | 1 diff (99.9 %id) | ||
DB123015 | thymus | .d | 1 to 569 | 2 to 570 | tiling clone, capped | 569/569 (100 %) | 1 diff (99.9 %id) | ||
DB123575 | thymus | .a | 1296 to 1905 | 2 to 611 | capped | 610/610 (100 %) | 0 diff (100 %id) | ||
TI_149274710 | .a | 1613 to 2059 | 518 to 73 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 446/1091 (40 %) | 4 diff (99.7 %id) | ||
TI_149279438 | .a | 1391 to 2033 | 91 to 733 | Submitted on the opposite strand | 643/764 (84 %) | 7 diff (99.1 %id) | |||
TI_149280748 | .a | 2899 to 3720 | 903 to 83 | AAA | 821/821 (100 %) | 15 diff (98.2 %id) | |||
TI_149284742 | .a | 2036 to 2623 | 665 to 78 | AAA | 588/1062 (55 %) | 10 diff (99.1 %id) | |||
TI_149310391 | .c | 244 to 875 | 698 to 66 | tiling clone, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 633/962 (65 %) | 6 diff (99.4 %id) | ||
TI_154021762 | .a | 2676 to 3378 | 791 to 89 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 703/704 (99 %) | 3 diff (99.6 %id) | ||
TI_154026851 | .a | 1290 to 2059 | 819 to 55 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 765/1207 (63 %) | 15 diff (98.8 %id) | ||
TI_154027902 | .a | 7071 to 7663 | 697 to 99 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 599/694 (86 %) | 69 diff (90.1 %id) | ||
TI_154048174 | .a | 2926 to 3720 | 881 to 88 | AAA | 794/1013 (78 %) | 10 diff (99.1 %id) | |||
TI_154136722 | .e | 97 to 647 | 14 to 562 | Submitted on the opposite strand | 549/1309 (41 %) | 6 diff (99.6 %id) | |||
TI_154140274 | .a | 1088 to 1654 | 682 to 115 | AAA | Submitted on the opposite strand | 568/571 (99 %) | 10 diff (98.3 %id) | ||
TI_154149157 | .a | 2178 to 2778 | 66 to 683 | 618/750 (82 %) | 50 diff (93.4 %id) | ||||
TI_154149652 | .a | 1073 to 1593 | 79 to 599 | 521/521 (100 %) | 7 diff (98.7 %id) | ||||
TI_154151779 | .a | 1072 to 1654 | 675 to 93 | AAA | Submitted on the opposite strand | 583/661 (88 %) | 5 diff (99.3 %id) | ||
TI_154153350 | .a | 1885 to 2493 | 80 to 688 | 609/609 (100 %) | 0 diff (100 %id) | ||||
TI_154155582 | .a | 3097 to 3545 | 78 to 526 | 449/449 (100 %) | 0 diff (100 %id) | ||||
TI_154157482 | .a | 7213 to 7664 | 560 to 109 | Submitted on the opposite strand | 452/478 (94 %) | 0 diff (100 %id) | |||
TI_154157605 | .a | 7075 to 7664 | 692 to 104 | AAA | Submitted on the opposite strand | 589/616 (95 %) | 0 diff (100 %id) | ||
TI_154161746 | .a | 3089 to 3644 | 633 to 78 | Submitted on the opposite strand | 556/559 (99 %) | 5 diff (99.2 %id) | |||
TI_154162364 | .a | 3138 to 3677 | 616 to 78 | Submitted on the opposite strand | 539/539 (100 %) | 16 diff (97.1 %id) | |||
TI_154164461 | .a | 850 to 1598 | 78 to 818 | 741/900 (82 %) | 12 diff (98.7 %id) | ||||
TI_154167676 | .a | 3282 to 3725 | 556 to 113 | AAA | Submitted on the opposite strand | 444/444 (100 %) | 0 diff (100 %id) | ||
TI_154167874 | .a | 3021 to 3717 | 93 to 798 | 706/869 (81 %) | 14 diff (98.4 %id) | ||||
TI_154174059 | .a | 2232 to 2746 | 82 to 603 | 522/674 (77 %) | 26 diff (96.2 %id) | ||||
TI_154174912 | .a | 7073 to 7664 | 696 to 104 | Submitted on the opposite strand | 593/693 (85 %) | 0 diff (100 %id) | |||
TI_154174960 | .a | 7067 to 7664 | 715 to 114 | Submitted on the opposite strand | 602/691 (87 %) | 0 diff (100 %id) | |||
TI_154180875 | .a | 1580 to 2414 | 73 to 909 | 837/839 (99 %) | 13 diff (98.5 %id) | ||||
TI_157609014 | .e | 97 to 643 | 50 to 594 | Submitted on the opposite strand | 545/601 (90 %) | 6 diff (99.1 %id) | |||
TI_159715093 | .a | 819 to 1654 | 924 to 93 | AAA | 830/1041 (79 %) | 19 diff (98.2 %id) | |||
TI_227712813 | .a | 898 to 1684 | 868 to 88 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 781/1046 (74 %) | 23 diff (97.9 %id) | ||
DB179945 | kidney, tumor tissue | .a | 1413 to 1943 | 2 to 532 | capped | 531/531 (100 %) | 0 diff (100 %id) | ||
BU678847 | lung, Primary Lung Epithelial Cells | .a | 1391 to 2033 | 26 to 668 | Submitted on the opposite strand | 643/666 (96 %) | 7 diff (99.0 %id) | ||
BU678847 | lung, Primary Lung Epithelial Cells | .a | 1391 to 2033 | 26 to 668 | Submitted on the opposite strand | 643/666 (96 %) | 7 diff (99.0 %id) | ||
BU688700 | lung, Primary Lung Epithelial Cells | .c | 259 to 866 | 615 to 9 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 607/623 (97 %) | 0 diff (100 %id) | |
BU688700 | lung, Primary Lung Epithelial Cells | .c | 259 to 866 | 615 to 9 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 607/623 (97 %) | 0 diff (100 %id) | |
BU607394 | Human Lung Epithelial cells, lung | .a | 2654 to 3360 | 719 to 13 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 707/707 (100 %) | 2 diff (99.8 %id) | |
BU607394 | Human Lung Epithelial cells, lung | .a | 2654 to 3360 | 719 to 13 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 707/707 (100 %) | 2 diff (99.8 %id) | |
CB241994 | Human Lung Epithelial cells, lung | .a | 2947 to 3720 | 792 to 19 | AAA | 774/774 (100 %) | 0 diff (100 %id) | ||
CB241994 | Human Lung Epithelial cells, lung | .a | 2947 to 3720 | 792 to 19 | AAA | 774/774 (100 %) | 0 diff (100 %id) | ||
BM662963 | eye, RPE and Choroid | .a | 3038 to 3720 | 700 to 18 | AAA | 683/683 (100 %) | 2 diff (99.8 %id) | ||
BM662963 | eye, RPE and Choroid | .a | 3038 to 3720 | 700 to 18 | AAA | 683/683 (100 %) | 2 diff (99.8 %id) | ||
BQ184276 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 9 to 682 | AAA | Submitted on the opposite strand | 674/682 (98 %) | 6 diff (99.2 %id) | |
BQ184276 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 9 to 682 | AAA | Submitted on the opposite strand | 674/682 (98 %) | 6 diff (99.2 %id) | |
BQ185986 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 699 to 25 | AAA | Submitted on the opposite strand | 675/685 (98 %) | 3 diff (99.6 %id) | |
BQ185986 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 699 to 25 | AAA | Submitted on the opposite strand | 675/685 (98 %) | 3 diff (99.6 %id) | |
BQ187335 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3399 to 3720 | 346 to 25 | AAA | Submitted on the opposite strand | 322/323 (99 %) | 13 diff (96.0 %id) | |
BQ187335 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3399 to 3720 | 346 to 25 | AAA | Submitted on the opposite strand | 322/323 (99 %) | 13 diff (96.0 %id) | |
CK300653 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 9 to 682 | AAA | Submitted on the opposite strand | 674/682 (98 %) | 6 diff (99.2 %id) | |
CK300653 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3046 to 3720 | 9 to 682 | AAA | Submitted on the opposite strand | 674/682 (98 %) | 6 diff (99.2 %id) | |
BM725072 | eye, fetal eye | .a | 2081 to 2801 | 1 to 721 | 721/721 (100 %) | 0 diff (100 %id) | |||
BM725072 | eye, fetal eye | .a | 2081 to 2801 | 1 to 721 | 721/721 (100 %) | 0 diff (100 %id) | |||
BU741972 | eye, fetal eye | .a | 3072 to 3720 | 667 to 19 | AAA | 649/649 (100 %) | 0 diff (100 %id) | ||
BU741972 | eye, fetal eye | .a | 3072 to 3720 | 667 to 19 | AAA | 649/649 (100 %) | 0 diff (100 %id) | ||
CA413238 | Chondrosarcoma Grade II, Left Pelvis | .a | 2992 to 3720 | 747 to 19 | AAA | 729/729 (100 %) | 1 diff (99.9 %id) | ||
CA413238 | Chondrosarcoma Grade II, Left Pelvis | .a | 2992 to 3720 | 747 to 19 | AAA | 729/729 (100 %) | 1 diff (99.9 %id) | ||
BU625225 | cell lines, Enchondroma | .a | 2984 to 3720 | 755 to 19 | AAA | 737/737 (100 %) | 0 diff (100 %id) | ||
BU625225 | cell lines, Enchondroma | .a | 2984 to 3720 | 755 to 19 | AAA | 737/737 (100 %) | 0 diff (100 %id) | ||
BQ774869 | Bone, Human Chondrosarcoma Cell Line | .a | 835 to 1623 | 797 to 9 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 789/797 (98 %) | 2 diff (99.8 %id) | |
BQ774869 | Bone, Human Chondrosarcoma Cell Line | .a | 835 to 1623 | 797 to 9 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 789/797 (98 %) | 2 diff (99.8 %id) | |
BU619155 | Cell Line, Chondrosarcoma | .a | 7171 to 7658 | 506 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 488/488 (100 %) | 0 diff (100 %id) | |
BU619155 | Cell Line, Chondrosarcoma | .a | 7171 to 7658 | 506 to 19 | AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 488/488 (100 %) | 0 diff (100 %id) | |
TI_153949268 | .j-u | 478 to 1266 | 85 to 862 | Y25X | tiling clone, | 778/1001 (77 %) | 25 diff (97.6 %id) | ||
DC420312 | uterus | .f | 1 to 486 | 1 to 486 | tiling clone, | 486/486 (100 %) | 0 diff (100 %id) | ||
DB294613 | .a | 2043 to 2863 | 2 to 823 | capped | 822/828 (99 %) | 9 diff (99.0 %id) | |||
DB384757 | .a | 4352 to 4901 | 547 to 1 | tiling clone, | 547/548 (99 %) | 19 diff (96.6 %id) |